Shell-and-core and build-to-suit manufacturing facilities on a 2.3-acre site in India's only manufacturing-zoned area of Genome Valley. Designed for established pharma, biotech, CDMO and medical device companies — domestic and international.
Available Space
We are retaining 10,000 sq ft for our own operations. The remaining site — across the existing one-acre plot and an adjacent 1.3-acre plot available exclusively to us — is offered on long-term lease terms, shell-and-core or turnkey to your specification.
Who We Suit
We suit both established domestic pharma companies looking for a shell-and-core finish they can fit out to their own standard, and international companies that want a fully turnkey, cleanroom-ready, manufacturing-ready solution from day one.
Finished dosage form, API, or specialty pharma companies requiring GMP-compliant manufacturing space. Shell-and-core delivery allows you to fit out fully to your regulatory standard — US FDA, EU GMP, or WHO — without compromise.
Contract development and manufacturing organisations expanding capacity in India's most cost-competitive cluster. Genome Valley's dense pharma ecosystem gives immediate access to raw material suppliers, API producers and established logistics networks.
European, US, Japanese and other international life sciences companies establishing their first India manufacturing base. Most companies build their own premises because no specialist developer meets this demand — we do. Full local support for regulatory, statutory and operational requirements is included.
Biotech companies requiring specialist manufacturing environments — biosafety, containment, specialist HVAC — or medical device manufacturers scaling production in India. The 1.3-acre adjacent plot enables full customisation of a purpose-built, standalone facility to your exact technical brief.
Why Hyderabad
Hyderabad is ranked by CBRE as one of the world's top seven life sciences clusters — alongside Boston, San Francisco, Oxford and Cambridge. It is India's fastest-growing life sciences hub, and the only city in Asia Pacific with both the manufacturing scale and the cost structure to compete directly with Western clusters.
The Team
Three principals with complementary expertise across international business development, Hyderabad operations, and on-the-ground project delivery. All three are also directly involved in building Patch House Labs — a transdermal pharmaceutical manufacturing business — on the existing site, giving us hands-on, day-one knowledge of what it takes to establish a GMP manufacturing operation in Genome Valley Phase III.
Isaac is the UK-based founder and originator of the Genome Valley Phase III opportunity. He leads international business development and is the primary point of contact for all tenant enquiries — from initial conversation through to heads of terms. Isaac identified and secured the Phase III land through TSIIC and structures the SPV and commercial arrangements for incoming tenants.
He is also the founder of Patch House Labs India, the transdermal manufacturing business being built on the existing site — giving him direct experience of navigating the full development process from land acquisition to GMP fit-out.
Vamsi is the Hyderabad-based Operations Director, overseeing all in-country activity across the site. His most significant asset is a direct relationship with the Telangana State Industrial Infrastructure Corporation (TSIIC) — the government body that controls land allocation in Genome Valley — which underpins our ability to offer the adjacent 1.3-acre plot on the same acquisition terms.
Vamsi manages contractor relationships, construction programme oversight, and the commercial and operational set-up of Patch House Labs India, where he holds an equity stake. His network within the Hyderabad life sciences community is central to our local execution capability.
Gopi is our experienced on-the-ground project manager, embedded full-time at the Phase III site. He brings deep knowledge of the local regulatory environment and has established working relationships with the authorities responsible for manufacturing licences, mains utility connections — power, water, and drainage — and operational clearances required to bring a facility into use.
His experience navigating TS-iPASS approvals and local statutory processes means that timelines and costs are known quantities rather than estimates. Gopi is also directly managing the construction and fit-out of Patch House Labs India on the existing site.
Location
The site sits within the Biotech Park Phase III development at Karkapatla Village, Mulugu Mandal, Medak District — approximately 45km north of Hyderabad city centre and 35km from Rajiv Gandhi International Airport. Phase III is the manufacturing-designated extension of the Genome Valley cluster, directly adjacent to existing SEZ and non-SEZ biotech operations.
How It Works
We provide a direct, low-friction pathway for companies to assess requirements, agree terms, and begin manufacturing in Hyderabad — without the delays and capital diversion of a self-build programme.
Enquire
We work with a focused number of tenants to ensure each project receives dedicated attention. Share your requirements and we will respond within 48 hours.
Most life sciences companies in India build their own premises because no specialist developer is meeting the demand. We are here to change that — providing the space, the expertise, and the local relationships so you can focus entirely on your manufacturing operations.
Tell us about your company and space requirements. All enquiries are treated in strict confidence.
All enquiries are treated in strict confidence. We do not share your details with third parties.